pindolol has been researched along with Sarcoidosis in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M | 1 |
| Takahashi, R | 1 |
| Ohtake, T | 1 |
| Komori, T | 1 |
| Nagashima, T | 1 |
| Tanabe, H | 1 |
1 other study available for pindolol and Sarcoidosis
| Article | Year |
|---|---|
[Pindolol-induced rhabdomyolysis in sarcoid myopathy].
Topics: Aged; Biopsy; Humans; Male; Muscles; Muscular Diseases; Pindolol; Rhabdomyolysis; Sarcoidosis | 1990 |